528 related articles for article (PubMed ID: 7527325)
1. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
Wagstaff AJ; Bryson HM
Drugs; 1994 Aug; 48(2):199-226. PubMed ID: 7527325
[TBL] [Abstract][Full Text] [Related]
2. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
Chrisp P; Clissold SP
Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982
[TBL] [Abstract][Full Text] [Related]
3. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
4. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
5. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
[TBL] [Abstract][Full Text] [Related]
6. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
Flores-Aguilar M; Kuppermann BD; Quiceno JI; Dankner WM; Wolf DG; Capparelli EV; Connor JD; Sherwood CH; Fullerton S; Gambertoglio JG
Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674
[TBL] [Abstract][Full Text] [Related]
8. Is combination antiviral therapy for CMV superior to monotherapy?
Drew WL
J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
Jabs DA; Dunn JP; Enger C; Forman M; Bressler N; Charache P
Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
[TBL] [Abstract][Full Text] [Related]
10. Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study.
Peters M; Schürmann D; Bergmann F; Grünewald T; Timm H; Pohle HD; Ruf B
Scand J Infect Dis; 1994; 26(1):49-54. PubMed ID: 8191240
[TBL] [Abstract][Full Text] [Related]
11. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
[TBL] [Abstract][Full Text] [Related]
13. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
15. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
Dunn JP; MacCumber MW; Forman MS; Charache P; Apuzzo L; Jabs DA
Am J Ophthalmol; 1995 May; 119(5):587-96. PubMed ID: 7733184
[TBL] [Abstract][Full Text] [Related]
16. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome.
Wilcox CM; Straub RF; Schwartz DA
Am J Med; 1995 Feb; 98(2):169-76. PubMed ID: 7847433
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151.
Jacobson MA; Kramer F; Bassiakos Y; Hooton T; Polsky B; Geheb H; O'Donnell JJ; Walker JD; Korvick JA; van der Horst C
J Infect Dis; 1994 Jul; 170(1):189-93. PubMed ID: 8014496
[TBL] [Abstract][Full Text] [Related]
19. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
[TBL] [Abstract][Full Text] [Related]
20. Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.
Jacobson MA; O'Donnell JJ
J Acquir Immune Defic Syndr (1988); 1991; 4 Suppl 1():S11-5. PubMed ID: 1848616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
